On August 1st, Tomer Feffer started his position as CEO of Bayer Sweden and of the company’s pharmaceutical division in Scandinavia.
“It is an honor and a privilege to take over as CEO of Bayer Sweden and become a part of the next phase of a journey that began 71 years ago with the establishment of Bayer in Sweden. The company has had an amazing journey with a sustainable growth during the last years. Sweden is one of the most innovative countries in the world and Bayer will continue to develop and make products available within healthcare and agriculture in collaboration with others,” said Feffer.
Feffer is from Israel and has most recently been the CEO of Bayer Israel, a position he has had held since 2011. He has also been Secretary-General of the Israelic pharmaceutical industry association and the CEO of a non-profit organization for human rights. He has studied economics and political science and he holds a MBA from Polytechnic in New York.
“Countries and cultures are different. With my strong faith in diversity and being including I see my move as an asset for new innovation as different perspectives come together,” said Feffer.
Feffer has moved to Sweden this summer and will replace Henrik Wulff, who now will take the role as responsible for Bayer’s activities in the Middle East, based in Dubai.